Metcela (メトセラ) is developing and commercializing an effective and reasonably-priced therapy for heart failure & cardiac diseases using specific fibroblast cells called VCF, which are obtained from the patient's own heart.
Company (Alive / Active)
Life Innovation Center #419
3-25-22 Tonomachi, Kawasaki-ku
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)